ADP-ribosylation governs the repair of topoisomerase IIIβ-induced nucleic acid damage
Abortive DNA and RNA-linked covalent cleavage complexes formed by the unique dual-activity human topoisomerase IIIβ (TOP3B) disrupt nucleic acid metabolism and can promote cancer cell death. Here, we identify poly(ADP-ribosylation) (PARylation) as a key pathway that regulates the repair and stability of both DNA- and RNA-linked TOP3B cleavage complexes (TOP3Bccs). We show that accumulated TOP3Bccs undergo rapid PARylation in a PARP1-dependent manner and that this modification is dynamically reversed by poly(ADP-ribose) glycohydrolase (PARG). Mass spectrometry identified major ADP-ribosylation sites on TOP3B, and disruption of these sites impaired TOP3Bcc homeostasis. Mechanistically, PARylation recruits flap endonuclease 1 (FEN1) to excise and repair TOP3Bccs. Persistent PARylation caused by PARG inhibition recruits the deubiquitylating enzyme (DUB) USP10 to promote TOP3Bcc deubiquitylation and thereby stabilize TOP3Bccs, presumably by preventing proteasomal degradation. Together, this study identifies a dynamic PARylation-mediated pathway that coordinates the repair of abortive TOP3Bccs. This pathway defines a critical mechanism of TOP3Bcc homeostasis and may influence cancer cell responses to TOP3B-targeting agents.
Authors
- Gerald M. Wilson (ORCID: https://orcid.org/0000-0002-1273-7507)
- Lisa M. Miller Jenkins (ORCID: https://orcid.org/0000-0003-1245-1338)
- Yves G. Pommier (ORCID: https://orcid.org/0000-0002-3108-0758)
- Yilun Sun (ORCID: https://orcid.org/0000-0002-6249-2704)
- Jiji Chen (ORCID: https://orcid.org/0000-0002-4426-3035)
- Tapan Kumar Maity (ORCID: https://orcid.org/0009-0003-0184-0239)
- Nina C. Lee (ORCID: https://orcid.org/0009-0003-5026-272X)
- Victor Cai
- B Wu (ORCID: https://orcid.org/0009-0009-1610-3892)
- Tessa Maidens (ORCID: https://orcid.org/0009-0009-7063-7430)
- Sourav Saha (ORCID: https://orcid.org/0000-0002-0854-5991)
- Linying Zhu
- Weixing Zhao
- Yijun Su
Institutions
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- National Institute of Biomedical Imaging and Bioengineering (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.19.767422
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- preprint